Category:Minggang ZHANG of New York NY (US)

Minggang ZHANG of New York NY (US)

Executive Summary

Minggang ZHANG of New York NY (US) is an inventor who has filed 2 patents. Their primary areas of innovation include PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (2 patents), Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations (2 patents), {Cellular immunotherapy} (2 patents), and they have worked with companies such as Memorial Sloan-Kettering Cancer Center (2 patents). Their most frequent collaborators include (2 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• A61K35/17 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
• A61K9/0019 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 2 patents
• A61K39/4611 ({Cellular immunotherapy}): 2 patents
• A61K39/4631 ({Cellular immunotherapy}): 2 patents
• A61K39/464466 ({Cellular immunotherapy}): 2 patents
• A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 2 patents
• A61P35/00 (Antineoplastic agents): 2 patents
• C07K14/705 (PEPTIDES (peptides in foodstuffs): 2 patents
• C12N5/0636 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 2 patents
• C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• A61K2239/31 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
• C12N2310/141 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• C12N2740/10043 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents

Companies

List of Companies

• Memorial Sloan-Kettering Cancer Center: 2 patents

Collaborators

• Morgan HUSE of New York NY (US) (2 collaborations)